Skip to main content
TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
4.630
+0.080 (1.76%)
At close: Jul 19, 2024, 4:00 PM
4.690
+0.060 (1.30%)
Pre-market: Jul 22, 2024, 7:26 AM EDT

TELA Bio Revenue

TELA Bio had revenue of $63.15M in the twelve months ending March 31, 2024, with 40.03% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $16.60M with 39.42% year-over-year growth. In the year 2023, TELA Bio had annual revenue of $58.45M with 41.13% growth.

Revenue (ttm)
$63.15M
Revenue Growth
+40.03%
P/S Ratio
1.81
Revenue / Employee
$278,181
Employees
227
Market Cap
114.15M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.45M17.04M41.13%
Dec 31, 202241.42M11.96M40.58%
Dec 31, 202129.46M11.25M61.77%
Dec 31, 202018.21M2.77M17.91%
Dec 31, 201915.45M7.17M86.68%
Dec 31, 20188.27M4.03M94.91%
Dec 31, 20174.25M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.57M
Karyopharm Therapeutics 140.46M
FONAR 102.72M
Akoya Biosciences 93.57M
Augmedix 48.70M
KORU Medical Systems 29.32M
Adagene 18.11M
aTyr Pharma 588.00K
Revenue Rankings

TELA News

More News